Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study
Diet and lifestyle modifications during treatment can dramatically influence outcomes with either Mounjaro or retatrutide
GPL-3 Peptide is a novel research compound studied for its interaction with multiple metabolic signaling pathways, including GLP-1, GIP, and glucagon receptors
Canagliflozin (Invokana) Dapagliflozin (Farxiga) Empagliflozin (Jardiance) Ertugliflozin (Steglatro) These medications are effective in lowering the A1c, which helps to protect heart and kidney function
That puts the drug one step from a filing
Summary of Benefits Fast eligibility quiz and onboarding No insurance required Transparent, flat-rate pricing Nationwide medication delivery Licensed clinical oversight and unlimited messaging Access to both compounded and name-brand GLP-1 medications These features make FuturHealth one of the most accessible and consumer-friendly options in the telehealth weight loss space